PACS Stock: Price, Earnings History and SEC Filings
PACS Group, Inc. (PACS) last traded at $47.81, down 3.76% on the latest session and up 15.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.63 against an analyst estimate of $0.55, a beat of 14.5%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PACS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.63 | $0.55 | +14.55% |
| Mar 2026 | May 11, 2026 | $0.50 | $0.42 | +19.05% |
| Dec 2025 | Feb 26, 2026 | $0.43 | $0.48 | -10.42% |
| Sep 2025 | Nov 19, 2025 | $0.32 | $0.46 | -30.43% |
PACS beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How PACS reacts to earnings
Across its last 8 earnings releases, PACS moved 23.4% on average the next session, in either direction. It rose after 6 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-04 | After close | +1.85% |
| 2026-05-11 | After close | +28.56% |
| 2026-02-26 | After close | -12.38% |
| 2025-11-19 | After close | +55.32% |
| 2025-09-11 | Before open | +24.51% |
| 2024-11-06 | Before open | -38.76% |
| 2024-08-12 | After close | +18.79% |
| 2024-05-13 | After close | +7.30% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
PACS financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $5.3B | $192M | – | 3.6% | $1.22 |
| 2024 | $4.1B | $56M | – | 1.4% | $0.38 |
| 2023 | $3.1B | $113M | – | 3.6% | $0.88 |
| 2022 | $2.4B | $150M | – | 6.3% | $1.17 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for PACS
- 8-K · Sep 21, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 4, 2026Results of operations, Financial statements and exhibits
- 10-Q · Aug 4, 2026
- 8-K · Jun 15, 2026Shareholder vote
- 8-K · May 11, 2026Results of operations, Financial statements and exhibits
- 10-Q · May 11, 2026
- DEF 14A · Apr 28, 2026
- 8-K · Apr 27, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Mar 5, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 10-K · Feb 27, 2026
Insider filing activity
PACS insiders filed 19 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
PACS news
- PACS Group Schedules Third Quarter 2026 Earnings Release and Conference CallOct 27, 2026 · finance.yahoo.com
- PACS Group CEO Jason Hulse Sells 82,613 Shares Under Rule 10b5-1 Plan in October 2026Oct 26, 2026 · kalkinemedia.com
- Medpace (MEDP) Q3 Earnings and Revenues Beat EstimatesOct 21, 2026 · finance.yahoo.com
About PACS Group, Inc.
PACS Group, Inc. (PACS) is a US-listed public company on NYSE. The SEC classifies its business as Services-skilled Nursing Care Facilities. It is incorporated in DE. Its fiscal year ends in December.